SLNO – soleno therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

SLNO

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/20

06:03 am

slno

Soleno Therapeutics (NASDAQ:SLNO) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.

Medium Report

Soleno Therapeutics (NASDAQ:SLNO) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.

Report

11/20

06:03 am

slno

Soleno Therapeutics (NASDAQ:SLNO) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.

Medium Report

Soleno Therapeutics (NASDAQ:SLNO) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.

Report

11/18

11:44 am

slno

Rating for SLNO

Low Report

Rating for SLNO

Report

11/18

11:44 am

slno

Rating for SLNO

Low Report

Rating for SLNO

Report

11/18

09:00 am

slno

Soleno Therapeutics (NASDAQ:SLNO) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $75.00 price target on the stock.

Medium Report

Soleno Therapeutics (NASDAQ:SLNO) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $75.00 price target on the stock.

Report

11/18

09:00 am

slno

Soleno Therapeutics (NASDAQ:SLNO) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $75.00 price target on the stock.

Medium Report

Soleno Therapeutics (NASDAQ:SLNO) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $75.00 price target on the stock.

Report

11/17

04:17 pm

slno

Soleno Therapeutics initiated with an Outperform at Wolfe Research

Low Report

Soleno Therapeutics initiated with an Outperform at Wolfe Research

Report

11/17

04:17 pm

slno

Soleno Therapeutics initiated with an Outperform at Wolfe Research

Low Report

Soleno Therapeutics initiated with an Outperform at Wolfe Research

Report

11/5

09:58 am

slno

Rating for SLNO

Low Report

Rating for SLNO

Report

11/5

09:58 am

slno

Rating for SLNO

Low Report

Rating for SLNO

Report

11/5

07:19 am

slno

Soleno Therapeutics (NASDAQ:SLNO) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.

Medium Report

Soleno Therapeutics (NASDAQ:SLNO) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.

Report

10/7

04:48 am

slno